RECENT PRODUCT NEWS

Diasorin and QIAGEN have announced the launch of the new CE-marked LIAISON QuantiFERON-TB Gold Plus II, a next-generation assay that redefines speed and throughput as an aid in the diagnosis of tuberculosis infection on LIAISON analyser systems.

Menarini has added Coyote FlashDetect PCR to its range of diagnostic solutions. These scalable rapid PCR devices will enable users to gain high quality results within 35 minutes.

QIAGEN has launched QIAsymphony Connect, the next generation of its widely adopted automated nucleic acid purification platform, at the 2025 AMP (Association for Molecular Pathology) annual meeting.

A new study has shown that Dragonfly, a low-cost, rapid, molecular testing platform is successfully able to detect asymptomatic malaria infections.

Precision proteomics firm Alamar Biosciences has announced the launch of the NULISAqpcr BD-pTau217 Assay, which it says is a transformative leap in blood-based quantification of brain-derived phosphorylated tau 217 (pTau217)—a pivotal biomarker in Alzheimer's disease research and other tauopathies.

Countable Labs has announced the launch of Countable 10, the first and only PCR platform capable of 10-color multiplexing. The new platform will extend the utility of the company’s core Countable PCR technology to enable higher level multiplexing that easily and cleanly reveals more insights in a single reaction.

Gestalt has announced the release of PathFlow Version 6, the latest evolution of its award-winning digital pathology platform.

Leica Biosystems has launched two new software solutions into its Aperio Digital Pathology portfolio.

Roche has recently announced the primary results from the TSIX Study Program, which evaluated the performance of its new sixth-generation high-sensitivity Troponin T test for diagnosing heart attacks.

Mindpeak has announced the European launch of PhenoScout AI, its advanced multiplex immunofluorescence (mIF) analysis solution, which it says sets a new standard with faster, reproducible and scalable insights for biomarker discovery and precision medicine.

Diagnostics firm BHR Biosynex has announced two exclusive distribution deals for new analyser platforms in the UK.

A new serology test for Lyme disease shows promise to streamline the testing protocol and to enable the diagnosis of patients in very early stages of the disease.

Beckman Coulter Diagnostics has launched the industry's first fully automated Brain-derived Tau (BD-Tau) research use only (RUO) immunoassay test.

Aiforia Technologies has launched a new CE-IVD marked clinical AI solution for lymph node metastasis detection.

Life sciences firm Eppendorf has announced the commercial launch of the Eppendorf Research 3 neo range of pipettes, designed to deliver accurate and precise results for accelerated volume selection, and optimised ergonomics.

Microbiology laboratory and automation firm Copan has launched UriVerse, a state-of-the-art, fully automated system that transforms the pre-analytical handling of urine specimens by automating key manual steps.

In response to recent outbreaks of Chikungunya fever, Anbio Biotechnology has announced the launch of its Chikungunya IgM/IgG Rapid Test, offering clinicians and public health authorities a fast, accessible diagnostic tool at the point of care. The company also has a new PCR system, for quicker POC results.

Agilent Technologies has announced the introduction of its Dako Omnis family of automated immunohistochemistry and in situ hybridisation instruments with three new models - Agilent Dako Omnis 110, 165, and 165 Duo - designed to meet the evolving needs of pathology laboratories of all sizes.

Torrey Pines Scientific has announced the new EchoTherm SC20 and SC25 Shaking, Chilling, Heating Dry Bath models. The SC20 is a simple digital unit while the SC25 is fully programmable, having a five-program memory making both ideal for use with biological and other samples.

Molecular diagnostics firm Seegene is to unveil its fully automated PCR testing system, CURECA, and data analytics platform, STAgora, at ADLM 2025.